STOCK TITAN
  1. Home
  2. News
  3. HIMS

Hims & Hers Health Inc - HIMS STOCK NEWS

Welcome to our dedicated news page for Hims & Hers Health (Ticker: HIMS), a resource for investors and traders seeking the latest updates and insights on Hims & Hers Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Hims & Hers Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Hims & Hers Health's position in the market.

News
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
Rhea-AI Summary
Hims & Hers Health, Inc. (NYSE: HIMS) will announce its first quarter 2024 financial results on May 6, 2024. The company will host a live conference call to discuss the results at 5:00 p.m. ET on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.01%
Tags
earnings
-
News
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
Rhea-AI Summary
Hims & Hers Health, Inc. appoints Christopher Payne to the Board of Directors to enhance its leadership in personalized health and wellness. Payne's extensive tech experience aims to drive growth and innovation within the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.47%
Tags
management
-
News
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
Rhea-AI Summary
Hims & Hers Health, Inc. management team to participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.47%
Tags
conferences
News
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
Rhea-AI Summary
Hims & Hers Health, Inc. (HIMS) reported strong financial results for Q4 2023 and full year 2023, with revenue reaching $872.0 million, up 65% year-over-year. The company achieved net income of $1.2 million and Adjusted EBITDA profitability of $20.6 million in Q4 2023. Subscribers grew to 1.5 million, up 48% year-over-year in Q4 2023. HIMS provided guidance for Q1 and full year 2024, expecting revenue between $1.17 billion to $1.20 billion and Adjusted EBITDA between $100 million to $120 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
31.02%
Tags
earnings
-
News
Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer
Rhea-AI Summary
Hims & Hers Health, Inc. announced the appointment of Dan Kenger as the Chief Design Officer to enhance the brand's digital-first health and wellness experience. Kenger's role involves overseeing design across the organization to create a personalized customer journey. With a background in creative leadership, Kenger aims to build trust and improve lives through innovative design.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.19%
Tags
none
-
News
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
Rhea-AI Summary
Hims & Hers Health, Inc. (NYSE: HIMS) will report Q4 and full year 2023 financial results on February 26, 2024. A live conference call will discuss the results, with upcoming participation in the Morgan Stanley Technology, Media & Telecom Conference on March 6, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.05%
Tags
earnings
News
Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care
Rhea-AI Summary
Hims & Hers Health, Inc. (NYSE: HIMS) partners with Hartford HealthCare to expand access to high-quality healthcare services in Connecticut.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
none
-
News
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
Rhea-AI Summary
Hims & Hers Health, Inc. (NYSE: HIMS) introduces Weight Loss by Hims & Hers, a personalized and affordable clinical program to help people achieve their weight-loss goals. Dr. Craig Primack, a pioneer in clinical obesity medicine, joins as SVP of Weight Management. The program is designed to address the underlying factors affecting weight through a holistic approach, combining medication management, digital tracking tools, and customized educational content.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
none
-
News
Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization
Rhea-AI Summary
Hims & Hers Health, Inc. announces a share repurchase program of up to $50 million of outstanding Class A common stock over the next two years. The program will be used to repurchase shares on a discretionary basis. The decision is driven by the Company's strong business performance and belief that its shares are trading below their intrinsic value. In the third quarter of 2023, revenue was up 57% YoY to $226.7 million, and the Company surpassed 1.4 million subscribers. Full-year revenue is expected to be between $868 and $873 million, up 65% to 66% YoY.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.99%
Tags
buyback
News
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
Rhea-AI Summary
Hims & Hers Health, Inc. reported strong financial results for Q3 2023, with revenue of $226.7 million, up 57% YoY, and a net loss of $7.6 million. The company achieved adjusted EBITDA profitability of $12.3 million. Subscribers grew to 1.4 million, up 56% YoY. Hims & Hers raised its full-year 2023 revenue guidance to a range of $868 million to $873 million and adjusted EBITDA guidance to a range of $43 million to $46 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.99%
Tags
earnings
Stock HIMS logo
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

#1665 Ranked by Market Cap
#709 Ranked by Stock Gains
N/A Ranked by Dividends

HIMS Stock Data

2.99B
172.45M
11.76%
61.72%
6.06%
Offices of Physicians, Mental Health Specialists
Health Care and Social Assistance
Link
US
Los Angeles

About HIMS

hims, inc. manufactures men's wellness products. it offers products, including hair loss prevention medicines, sexual wellness products, skincare products, and oral care products. the company also provides sweaters, jackets, corduroy, sport coats, wool overcoat, leather boots, flannel, shirts, caps, and candles. it sells its products online. the company was incorporated in 2013 and is based in san francisco, california.